Chapters

Transcript

Video

Trial 20-153: SACI-IO for Hormone Receptor Positive Metastatic Breast Cancer

Why test the combination of Trodelvy and pembrolizumab? Previous efforts testing immunotherapy for HR+ breast cancer has shown disappointing results.

Related Presenters

Filipa Lynce, MD.

Filipa Lynce, MD

Medical Oncology

View Profile

ADVERTISEMENT

Related Videos